|
× |
 |
Trends in Receipt of Mental Health Treatments Among Adults in the United States, 2008-2013 PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Prospective Study of Hormone Therapy and Depression in Community-Dwelling Elderly Women: The Three City Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Stalking and COVID-19: Consequences of a Pandemic PDF |
$40.00 |
|
$40.00 |
|
× |
|
Polypharmacy in Children and Adolescents Treated for Major Depressive Disorder: A Claims Database Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Treatment of Generalized Anxiety Disorder: A Comprehensive Review of the Literature for Psychopharmacologic Alternatives to Newer Antidepressants and Benzodiazepines PDF |
$40.00 |
|
$40.00 |
|
× |
|
High-Deductible Health Plans Paired With Health Savings Accounts Increased Medication Cost Burden Among Individuals With Bipolar Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Lurasidone-Induced Dystonia PDF |
$40.00 |
|
$40.00 |
|
× |
|
Happiness During Low-Dose Ketamine Infusion Predicts Treatment Response: Reexploring the Adjunctive Ketamine Study of Taiwanese Patients With Treatment-Resistant Depression PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Case of Stevens-Johnson Syndrome After Exposure to Valproic Acid PDF |
$40.00 |
|
$40.00 |
|
× |
|
Severe Catatonia Following Sudden Withdrawal of Quetiapine PDF |
$40.00 |
|
$40.00 |
|
× |
|
Effects of Olanzapine on Prolactin Levels of Female Patients With Schizophrenia Treated With Risperidone PDF |
$40.00 |
|
$40.00 |
|
× |
|
Effectiveness and Safety of Intravenous Ketamine for Severely Depressed Patients Unable to Receive Electroconvulsive Therapy Due to Medical Risks PDF |
$40.00 |
|
$40.00 |
|
× |
|
Family and Partner Psychopathology and the Risk of Postpartum Mental Disorders PDF |
$40.00 |
|
$80.00 |
|
× |
|
Randomized Clinical Trial of Bright Light Therapy for Antepartum Depression: Preliminary Findings PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Placebo-Controlled Trial of Cognitive-Behavioral Therapy and Clomipramine in Trichotillomania PDF |
$40.00 |
|
$40.00 |
|
× |
|
Double-Blind Treatment With Oral Morphine in Treatment-Resistant Obsessive-Compulsive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Paroxetine in Social Phobia PDF |
$40.00 |
|
$40.00 |
|
|
